Selected Publications
Moskovljevic, M., Dragoni, F., Board, N. L., Wu, F., Lai, J., Zhang, H., White, J. R., Hoh, R., Lynn, K., Tebas, P., Mounzer, K., Deeks, S. G., Montaner, L. J., Siliciano, J. D., Siliciano, R. F., Simonetti, F. R.: Cognate antigen engagement induces HIV-1 expression in latently infected CD4(+) T cells from people on long-term antiretroviral therapy Immunity : 2024.
Gulick, R. M., Pau, A. K., Daar, E., Evans, L., Gandhi, R. T., Tebas, P., Ridzon, R., Masur, H., Lane, H. C., Nih Covid- Treatment Guidelines Panel, Adimora, A. A., Baker, J., Kreuziger, L. B., Bedimo, R., Belperio, P., Bhalla, A., Burgess, T., Campbell, D., Cantrill, S., Chew, K., Chiotos, K., Coopersmith, C., Davey, R., Dzierba, A., Eisnor, D., Eschenauer, G., Francis, J., Gallagher, J., Glidden, D., Goldenberg, N., Grund, B., Han, A., Hardy, E., Harrison, C., Henderson, L., Higgs, E., Hinkson, C., Hughes, B., Johnson, S., Keller, M., Kim, A., Knight, R., Kuriakose, S., Lennox, J., Lerner, A., Levy, M., Li, J., MacBrayne, C., Martin, G., Nadig, N., Nason, M., Patel, P., Pavia, A., Proschan, M., Schulert, G., Seam, N., Sheikh, V., Simpson, S., Singh, K., Swindells, S., Tien, P., Uyeki, T., Waghmare, A., Wolfe, C., Yazdany, J., Aberg, J.: National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned Ann Intern Med 177 (11): 1547-1557,2024.
Pahus, M. H., Zheng, Y., Olefsky, M., Gunst, J. D., Tebas, P., Taiwo, B., Sogaard, O. S., Peluso, M. J., Lie, Y., Reeves, J. D., Petropoulos, C. J., Caskey, M., Bar, K. J.: Evaluation and real-world experience of a neutralization susceptibility screening assay for broadly neutralizing anti-HIV-1 antibodies J Infect Dis : 2024.
Bhimraj, A., Falck-Ytter, Y., Kim, A. Y., Li, J. Z., Baden, L. R., Johnson, S., Shafer, R. W., Shoham, S., Tebas, P., Bedimo, R., Cheng, V. C., Chew, K. W., Chiotos, K., Daar, E. S., Dzierba, A. L., Glidden, D. V., Hardy, E. J., Martin, G. S., MacBrayne, C., Nadig, N., Nakamura, M. M., Shumaker, A. H., Tien, P., Loveless, J., Morgan, R. L., Gandhi, R. T.: 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis Clin Infect Dis : 2024.
Papasavvas, E., Lu, L., Fair, M., Oliva, I., Cassel, J., Majumdar, S., Mounzer, K., Kostman, J. R., Tebas, P., Bar-Or, A., Muthumani, K., Montaner, L. J.: Cloning and Functional Characterization of Novel Human Neutralizing Anti-IFN-alpha and Anti-IFN-beta Antibodies J Immunol 213 (6): 808-822,2024.
Lee, M. J., Eason, M., Castagna, A., Laura, G., De Scheerder, M. A., Riley, J., Tebas, P., Gunst, J., Sogaard, O., Florence, E., Kroon, E., De Souza, M., Mothe, B., Caskey, M., Fidler, S.: The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis J Int AIDS Soc 27 (8): e26349,2024.
Hamilton, K. W., Hua, E., Dutcher, L., Fernandez Lynch, H., Junker, P., Doucette, A. G., Werner, D., Kannel, E. Z., Civitello, T., Gabriel, P., Ahya, V. N., Jacobs, D. A., Garfall, A., Pratz, K., Degnan, K. O., Blumberg, E. A., Capozzi, D., Craig, E., Takach, P., Payne, A. S., Geara, A., Koenig, H., Holzman, L., Tebas, P.: Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center Open Forum Infect Dis 11 (8): ofae388,2024.
Molina, J. M., Rizzardini, G., Orrell, C., Afani, A., Calmy, A., Oka, S., Hinestrosa, F., Kumar, P., Tebas, P., Walmsley, S., Grandhi, A., Klopfer, S., Gendrano, I., Eves, K., Correll, T. A., Fox, M. C., Kim, J.: Switch to fixed-dose doravirine (100 mg) with islatravir (0.75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial Lancet HIV 11 (6): e369-e379,2024.
Jacobson, J. M., Felber, B. K., Chen, H., Pavlakis, G. N., Mullins, J. I., De Rosa, S. C., Kuritzkes, D. R., Tomaras, G. D., Kinslow, J., Bao, Y., Olefsky, M., Rosati, M., Bear, J., Heptinstall, J. R., Zhang, L., Sawant, S., Hannaman, D., Laird, G. M., Cyktor, J. C., Heath, S. L., Collier, A. C., Koletar, S. L., Taiwo, B. O., Tebas, P., Wohl, D. A., Belaunzaran-Zamudio, P. F., McElrath, M. J., Landay, A. L., Actg Study Team: The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy AIDS 38 (7): 963-973,2024.
Papasavvas, E., Lu, L., Fair, M., Oliva, I., Cassel, J., Majumdar, S., Mounzer, K., Kostman, J. R., Tebas, P., Bar-Or, A., Muthumani, K., Montaner, L. J.: Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies bioRxiv : 2024.
Academic Contact Information
Academic Address: 502 Johnson Pavilion
Clinical Office: 4 Perelman Center for Advanced Medicine, 3600 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-349-8092
Patient appointments: 800-789-7366